<unk> (25%) is a sterile intravenous solution that is FDA approved for the treatment of acute symptomatic episodes of hypoglycemia in the neonate or older infant to restore depressed blood glucose levels and control symptoms.   Common adverse reactions include hyperosmolar syndrome, febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, and extravasation.
Dextrose monohydrate injection 
Intravenous sugar solution
Vasopressin injection
Machine perfusion
Lethal injection
Blood transfusion
AutoPulse machine
Gastric suction